Radiochemist
Dion has performed a PhD research project at the VU University Medical Centre. In this project, he has developed a novel methodology to incorporate a fluorine-18 labelled trifluoromethyl (CF3) functional group onto an aromate. This method enables the radiolabelling and biological evaluation of drugs and drug candidates which contain the CF3 group.
As a radiochemist at FutureChemistry, Dion is responsible for the development of radiolabelled compounds and their biological evaluation.